Referral to Hepatology Low With Excessive Alcohol Use, High FIB-4

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 7, 2024.

By Elana Gotkine and Mark Arredondo, M.D. HealthDay Reporters

MONDAY, Oct. 7, 2024 -- Only 37 percent of patients with excessive alcohol use (EAU) and a high fibrosis-4 index (FIB-4) are referred to hepatology, according to a study published online Sept. 21 in Alcohol: Clinical & Experimental Research.

Kevin Houston, M.D., from Virginia Commonwealth University in Richmond, and colleagues extracted records of patients with excessive alcohol use between 2013 and 2023 and compared those referred to versus not referred to hepatology.

Overall, 1,131 individuals showed evidence of EAU, and of these,189 were in alcohol remission; the remaining 942 individuals were further analyzed for FIB-4 score and referral patterns. The researchers found that 316 patients had active EAU and high FIB-4; 37 percent were referred to hepatology. The likelihood of being referred was lower for patients with alcohol-related mental health concerns and those admitted for trauma. Referral was higher with alcohol-related liver hospitalizations and a higher Charlson Comorbidity Index (odd ratios, 9.25 and 6.23, respectively) and was lower with mental health admissions or mental health diagnoses and with increasing age (odds ratios, 0.36, 0.36, and 0.95, respectively).

"Greater education of mental health providers and for teams taking care of inpatients admitted with alcohol-related mental health concerns would better integrate care and could improve outcomes for patients with higher risk for advanced liver disease," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-08 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords